Showing results (91-100 of 108) with videos related to
Sort By:
Pageof 11
Scientific Reports|October 28, 2014
A human CCT5 gene mutation causing distal neuropathy impairs hexadecamer assembly in an archaeal modelWonki Min, Francesca Angileri, Haibin Luo, et al.Open Forum Infectious Diseases|April 13, 2019
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cARTIacopo Franconi, Caterina Monari, Marco Tutone, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2021
Effectiveness of a screening program for HBV, HCV, and HIV infections in African migrants to SicilyTullio Prestileo, Vito Di Marco, Ornella Dino, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 30, 2024
Promoting readthrough of nonsense mutations in CF mouse model: Biodistribution and efficacy of NV848 in rescuing CFTR protein expressionIgnazio Fiduccia, Federica Corrao, Maria Grazia Zizzo, et al.Journal of Molecular Graphics & Modelling|July 12, 2025
In silico-guided exploration of SIRT6 modulation: Discovery of new fragments hits inhibitorsIgnazio Sardo, Giulia Culletta, Ugo Perricone, et al.International Journal of Molecular Sciences|October 28, 2023
Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene ExpressionRiccardo Perriera, Emanuele Vitale, Ivana Pibiri, et al.Clinical Case Reports|December 9, 2024
Cerebral Fat Embolism After Traumatic Long-Bone Fracture: A Case ReportMariachiara Ippolito, Vincenzo Benenati, Valentina Gambino, et al.Current Pharmaceutical Design|October 25, 2012
Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs designAndrea Pace, Giampaolo Barone, Antonino Lauria, et al.European Biophysics Journal : EBJ|June 27, 2025
Modulation of conformational features and oligomerization of MMACHC by cobalamin variants: impact of the R161Q mutation in cblC diseaseLisa Longo, Maria Assunta Costa, Rita Carrotta, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2025
A precision medicine approach to primary immunodeficiency disease: Ataluren strikes nonsense mutations once againLaura Lentini, Riccardo Perriera, Federica Corrao, et al.Pageof 11